GC Cell Initiates First Patient Dosing in Phase 1 Clinical Trial for GCC2005, a Promising T‘Cell Lymphoma CD5 CAR-NK Therapy

8 months ago 47

1. Homepage
2. Finance
3. GC Cell Initiates First Patient Dosing in Phase 1 Clinical Trial for GCC2005, a Promising T‘Cell Lymphoma CD5 CAR-NK Therapy